In October 2022 the India National Anti-Doping Agency (INADA) has reported an anti-doping rule violation against the judoka Jibanlata Laishram Devi after her A and B samples tested positive for the prohibited substance 19-norandrosterone (Nandrolone).
Following notification a provisional suspension was ordered. The Athlete filed a statement in her defence and she was heard for the Anti-Doping Disciplinary Panel of India (ADDPI).
The Athlete denied the intentional use of the substance and could not explain how the substance had entered her system. She suggested that the prescribed medication, supplements or food she prior had used might be the source of the prohibited substance.
The Panel finds that the presence of a prohibited substance has been established in her samples and accordingly that she committed an anti-doping rule violation.
The Panel deems that the Athlete failed to demonstrate that the violation was not intentional, nor how the substance had entered her system. The Panel concludes that she had acted ignorant and negligently.
Therefore the Panel decides on 28 March 2023 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 6 October 2022.